Management of the clinically negative neck (N0) of supraglottic laryngeal carcinoma: A systematic review

被引:24
作者
Goudakos, J. K. [1 ]
Markou, K. [1 ]
Nikolaou, A. [1 ]
Themelis, C. [1 ]
Vital, V. [1 ]
机构
[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Otorhinolaryngol 1, GR-54006 Thessaloniki, Greece
来源
EJSO | 2009年 / 35卷 / 03期
关键词
Supraglottic carcinoma; Clinically negative neck; N0; Neck dissection; UPPER AERODIGESTIVE TRACT; SQUAMOUS-CELL CARCINOMA; CERVICAL NODE METASTASES; SELECTIVE NECK; LYMPH-NODES; PROGNOSTIC-SIGNIFICANCE; OCCULT METASTASES; DISSECTION; CANCER; HEAD;
D O I
10.1016/j.ejso.2008.04.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The most effective therapeutic approach for patients with supraglottic laryngeal carcinoma (SGLC) and clinically negative neck (cN0) remains a subject of much debite. The purpose of this systematic review was to answer the following question: among patients with SGLC and cN0 neck, are the survival and Occurrence of neck metastases significantly different between patients that received neck dissection and those that had another therapeutic treatment (radiotherapy, combined therapy, 'wait and see' policy)? Materials and methods: An electronic literature search was performed in MEDLINE, EMBASE, Cochrane Library and CENTRAL databases, followed by extensive hand-searching for the identification of relevant studies. The following inclusion criteria were established: the study should (a) include a comparison of neck dissection with one of the other therapeutic procedures for cN0 of SGLC (b) report the therapy for the initial supraglottic cancer; and (c) use time-to-event analysis of its results. Six studies were eventually identified and systematically reviewed. Results: All studies included in the systematic review were retrospective (n = 792 patients). The survival (overall, disease-specific and neck disease-free) and the site of neck recurrence of the patients with NO supraglottic cancer were not significantly different between patients in the neck dissection treatment group and those of the rest of the therapeutic strategies examined (neck radiotherapy, combined therapy and 'wait and see' policy). Conclusions: The present systematic review highlights the need for further well-designed prospective studies that will provide more reliable answers to (lie debatable issue of the management of cN0 of SGLC. Currently, based on the best available evidence, it seems that neck dissection is not superior to radiotherapy or combined therapy or a 'wait and see' policy in terms of survival and control of neck disease. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 58 条
  • [1] Ambrosch P, 1996, EUR ARCH OTO-RHINO-L, V253, P329
  • [2] The extent of neck disease after regional failure during observation of the no neck
    Andersen, PE
    Cambronero, E
    Shaha, AR
    Shah, JP
    [J]. AMERICAN JOURNAL OF SURGERY, 1996, 172 (06) : 689 - 691
  • [3] [Anonymous], 2002, META ANAL CONTROLLED
  • [4] BAREDES S, 1985, LARYNGOSCOPE, V95, P151
  • [5] Molecular assay to detect metastatic head and neck squamous cell carcinoma
    Becker, MT
    Shores, CG
    Yu, KK
    Yarbrough, WG
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (01) : 21 - 27
  • [6] Brentani RR, 1999, HEAD NECK-J SCI SPEC, V21, P694
  • [7] Buckley JG, 2000, HEAD NECK-J SCI SPEC, V22, P380, DOI 10.1002/1097-0347(200007)22:4<380::AID-HED11>3.0.CO
  • [8] 2-E
  • [9] Surgical treatment of cervical node metastases from squamous carcinoma of the upper aerodigestive tract: Evaluation of the evidence for modifications of neck dissection
    Buckley, JG
    Feber, T
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (10): : 907 - 915
  • [10] Byers RM, 1999, HEAD NECK-J SCI SPEC, V21, P499, DOI 10.1002/(SICI)1097-0347(199909)21:6<499::AID-HED1>3.0.CO